FDA approves St. Jude Medical’s spinal cord stimulation therapy

St. Paul, Minn.-based St. Jude Medical earned Food and Drug Administration approval for its BurstDR stimulation technology, a physician-developed form of spinal cord stimulation used to treat patients with chronic pain.

Advertisement

Spinal cord stimulation uses an implant, placed near the spinal cord, to deliver mild electrical stimulation to the nerves along the spinal column to block pain messages from reaching the brain.

St. Jude’s BurstDR stimulation uses intermittent bursts of electrical pulses to copy the body’s natural nerve impulse patterns, according to the report.

Patients receiving stimulation implants from St. Jude will now have access to the new therapy and those already implanted with the devices will be able to upgrade their systems to administer BurstDR stimulation without additional surgery, the company said.

 

More articles on supply chain:

5 factors driving supply chain innovation
FDA approves Teva’s generic HIV drug
Hospital bed company LINET buys majority stake in BORCAD Medical

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.